Crcle Guaifenesin Extended-Release Tablets, 600 mg 600 mg/1
Guaifenesin Extended-Release · TABLET · Innovus Pharmaceuticals, Inc.
Crcle Guaifenesin Extended-Release Tablets are an over-the-counter medication that helps thin and loosen mucus to make coughs more productive. This expectorant is commonly used to relieve chest congestion caused by colds, flu, or other respiratory conditions.
Key Facts
- Brand Name
- Crcle Guaifenesin Extended-Release Tablets, 600 mg
- Generic Name
- Guaifenesin Extended-Release
- NDC Code (Product)
57483-270- Manufacturer
- Innovus Pharmaceuticals, Inc.
- Strength
- 600 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA213420
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 09/10/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Crcle Guaifenesin Extended-Release Tablets, 600 mg used for?
Crcle Guaifenesin Extended-Release Tablets are an over-the-counter medication that helps thin and loosen mucus to make coughs more productive. This expectorant is commonly used to relieve chest congestion caused by colds, flu, or other respiratory conditions.
Is Crcle Guaifenesin Extended-Release Tablets, 600 mg a controlled substance?
Crcle Guaifenesin Extended-Release Tablets, 600 mg is not classified as a controlled substance by the DEA.
What is the generic name for Crcle Guaifenesin Extended-Release Tablets, 600 mg?
The generic name for Crcle Guaifenesin Extended-Release Tablets, 600 mg is Guaifenesin Extended-Release. There are no other listed brand versions of Guaifenesin Extended-Release.
What is the NDC code for Crcle Guaifenesin Extended-Release Tablets, 600 mg 600 mg/1?
The NDC (National Drug Code) for Crcle Guaifenesin Extended-Release Tablets, 600 mg 600 mg/1 is 57483-270, listed by Innovus Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)